We are live on ! Find out more
LA

Lee Ainslie Maverick Capital

AUM $11.3B
1-Year Est. Return 76.6%
 

Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.

This Fund
S&P 500
This Quarter Est. Return
+0.99%
1 Year Est. Return
+76.6%
3 Year Est. Return
+266.43%
5 Year Est. Return
+219.63%
10 Year Est. Return
+601.38%
AUM
$8.85B
AUM Growth
-$1.07B
Cap. Flow
-$1.02B
Cap. Flow %
-11.52%
Top 10 Hldgs %
56.72%
Holding
681
New
56
Increased
52
Reduced
179
Closed
373

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$150M
2
V icon
Visa
V
+$84.7M
3
TGTX icon
TG Therapeutics
TGTX
+$71.1M
4
MA icon
Mastercard
MA
+$70.2M
5
ATVI
Activision Blizzard
ATVI
+$66.5M

Top Sells

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$279M
2
CNC icon
Centene
CNC
+$257M
3
ONEM
1Life Healthcare
ONEM
+$74.1M
4
IFF icon
International Flavors & Fragrances
IFF
+$69M
5
SEER icon
Seer Inc
SEER
+$66M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 43.56%
2 Technology 17.09%
3 Healthcare 11.19%
4 Communication Services 9.35%
5 Financials 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSKA
676
DELISTED
Heska Corp
HSKA
– –
-1,442
Closed -$373K
STMP
677
DELISTED
Stamps.com, Inc.
STMP
– –
-1,382
Closed -$456K
VG
678
DELISTED
Vonage Holdings Corporation
VG
– –
-953
Closed -$15K
CIT
679
DELISTED
CIT Group Inc.
CIT
– –
-19,872
Closed -$1.03M
BHVN
680
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-1,572
Closed -$218K
CADE
681
DELISTED
Cadence Bancorporation
CADE
– –
-20,043
Closed -$440K
24 25 26 27
28

Similar funds

GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
CC
Centiva Capital New York $11.5B AUM 31.97% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Lee Ainslie's Q4 2021 Portfolio in Review

As of Q4 2021, Lee Ainslie held 681 positions worth $8.85B, down 11% from $9.92B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Lee Ainslie withdrew a net $1.02B in Q4 2021, closing 373 positions and reducing 179 holdings. Its most notable exit was Centene, an estimated $257M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Lee Ainslie opened a new position in Rivian worth $51.8M.

  • Lee Ainslie's largest Q4 2021 buy was Rivian: 500,000 shares worth $51.8M.
  • Lee Ainslie added most to Oak Street Health, Inc. in Q4 2021, an estimated $150M increase.
  • Lee Ainslie's biggest Q4 2021 reduction was Coupang, cutting an estimated $279M.
  • Lee Ainslie fully exited Centene in Q4 2021, selling an estimated $257M.
  • Lee Ainslie's ten largest holdings make up 57% of its $8.85B portfolio in Q4 2021.
  • Lee Ainslie opened 56 new positions and closed 373 in Q4 2021.
  • Lee Ainslie's portfolio value fell 11% quarter-over-quarter to $8.85B.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.